Ghov-28 ((new))

To understand , one must first understand the logic behind its naming convention. Unlike commercial drug names (which end in "-mab" for monoclonal antibodies or "-ib" for enzyme inhibitors), the code GHOV-28 suggests a proprietary internal cataloging system, likely from a specialized biochemical supplier or a university research lab.

A theoretical application of GHOV-28 involves reducing senescence in stressed cell lines. By upregulating sirtuin pathways, the peptide might delay replicative exhaustion, though these findings require rigorous replication. ghov-28